Suzhou Key Laboratory for Metabolic Syndrome New Drug Research was established in 2010. It is the first of its kind in the Chinese mainland. With a total investment of more than 40 million RMB, it is committed to exploring the molecular mechanisms of disease, system and structural biology, protein and bioengineering, cell communication and new drug research at the molecular and cellular level.
The laboratory encourages industry-university-research cooperation and interdepartmental collaboration. It contributes to scientific research instruments, and supports disciplinary research in corresponding fields.